Sandy Agnew joined last week from Euro RSCG Life MedEd & PR, where she was a senior account director for less than a year.
Prior to Euro RSCG she worked for Novartis, latterly as UK senior health comms manager. Thomson was UK head of health comms at Novartis, where Agnew reported to her, before leaving last year (PRWeek, 15 April 2005).
Agnew, who also worked in regulatory affairs and clinical research for Novartis, shares responsibility for med ed business with fellow business director Cathy McDonnell.
Avenue's main med ed accounts are Plavix (for Sanofi-Aventis/Bristol-Myers Squibb), Keppra (for UCB) and Alvesco (for Altana Pharma).